Related Experiment Video
Updated: Jan 26, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis
Siroj Dejhansathit1, Attaya Suvannasankha1
11 Indiana University School of Medicine, Indianapolis, IN, USA.
Abstract:
Acquired factor X (FX) deficiency is a rare but serious complication of primary amyloidosis, presumably caused by the binding of amyloid proteins to the clotting factors. The prolonged prothrombin time, partial thromboplastin time, and low FX level, which are correctable by mixing study, are the disease hallmarks. An immediate goal of care is to stop bleeding. Clotting factor replacement requires close monitoring of coagulogram and FX levels due to varying FX clearance among patients. High-purity FX is currently approved for hereditary FX deficiency and has been successfully used in some acquired FX deficiency cases. Ongoing bleeding risk complicates the treatment decision. Novel therapies yielding rapid and deep response reduce amyloid protein production and improve long-term outcome.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Electron Transport Chains
The ETC is comprised of...
Radical Chain-Growth Polymerization: Chain Branching
Transcription Factors
The Chain Rule
Factors Affecting Solubility

